Cardiovascular Pharmacotherapy

Evidence-Based Solutions for Clinical Practice
1. Auflage 2026
ISBN: 978-1-041-07842-5
Verlag: Taylor & Francis Ltd

Buch, Englisch, 224 Seiten, Format (B × H): 178 mm x 254 mm

This comprehensive guide to cardiovascular pharmacotherapy provides a clinically oriented overview of drugs in the field of cardiology. Written for healthcare professionals, it integrates latest evidence with clinical decision-making. The book emphasizes practical, evidence-based approaches to drug use, featuring step-by-step therapeutic algorithms to support everyday clinical practice.

Key Features:

- Summarizes current cardiovascular therapies, integrating pharmacological mechanisms with clinical evidence.

- Bridges science and practice, offering practical guidance for real-world clinical decision-making.

- Delivers comprehensive disease-oriented pharmacological approaches, guiding clinicians on how to use and combine drugs effectively for each cardiovascular condition.

Zielgruppe

Professional Practice & Development

Autoren/Hrsg.

Greco, Antonio

Capodanno, Davide

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete AINS Intensivmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie

Inhaltsverzeichnis

PART I – Cardiovascular Drugs and Clinical Applications

1. Anti-Anginal Drugs

2. Anti-Arrhythmic Drugs

3. Antithrombotic Drugs
4. Beta-Blockers
5. Calcium-Channel Blockers
6. Diuretics

7. Glucagon-Like Peptide-1 Receptor Agonists

8. Lipid-Lowering Drugs

9. Renin-Angiotensin-Aldosterone System Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor

10. Sodium-Glucose Cotransporter 2 Inhibitors

PART II – Integrated Disease Management: Practical Approaches

11. Coronary Artery Disease

12. Arrhythmias

13. Cardiomyopathies

14. Deep Vein Thrombosis and Pulmonary Embolism

15. Diabetes, Obesity and Metabolic Syndrome

16. Dyslipidemias

17. Heart Failure and Cardiogenic Shock

18. Hypertension

19. Inflammatory and Autoimmune Diseases

20. Pulmonary Hypertension

21. Stroke

Über Autor(innen)

Antonio Greco

Dr. Antonio Greco, MD, PhD, is a Consultant Cardiology at the Cardiovascular Department, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico—San Marco", University of Catania (Catania, Italy). He earned his MD (Medicine and Surgery) and PhD (Translational Biomedicine) degrees at the University of Catania (Catania, Italy). He also completed an advanced university course on “Biomedical Statistics Applied to Research in the Human Field” at the University of Palermo (Palermo, Italy) and a Second Level Master’s Degree (Advanced Biostatistics for Clinical Research) at the University of Padua (Padua, Italy).

He is the recipient of a highly competitive Research Grant funded by the Italian Ministry of University and Research. He has published more than 80 papers in peer-reviewed international Journals and contributed to multiple chapters and textbooks in the field of cardiology. He has served as a Scientific Consultant for the European Commission and as a volunteer for the European Society of Cardiology. He has delivered over 30 invited lectures at national and international scientific meetings. His research activities mainly focus on cardiovascular pharmacotherapy, antithrombotic therapy, atherosclerotic cardiovascular disease, and cardiovascular prevention.

Davide Capodanno

Davide Capodanno, MD, PhD, is Full Professor of Cardiology at the University of Catania, Director of the Postgraduate School of Cardiovascular Diseases, and Director of the Cardiology Division at the Azienda Ospedaliero-Universitaria Policlinico “G. Rodolico–S. Marco” in Catania, Italy. He earned his MD and PhD from the University of Catania and completed advanced research training at the University of Florida, Jacksonville.

He has authored more than 750 peer-reviewed publications and contributed to five textbooks and multiple chapters in interventional cardiology. He has delivered over 400 invited lectures at international scientific meetings, including ESC, ACC, EuroPCR, TCT, and TCTAP. His research focuses on coronary revascularization, antithrombotic therapy, clinical trial methodology, and biostatistics.